Tatton Weekly

November brought investors the opposite of October and turned most portfolio returns into positive mid-single-digit numbers for the year. As we have written here over the past weeks, the distinct turn in sentiment that drove markets in November was, once again, mostly...

Type-2 diabetes and obesity ‘GLP-1’ drugs Ozempic and Wegovy have been hailed as breakthrough treatments. They work by mimicking the hormone released after eating which increases insulin production, reducing appetite and ultimately making patients feel fuller. The health benefits of combating obesity...

Overview: activity (and growth) slows down as December beckons The US-centric nature of global markets means Thanksgiving week tends to be quiet. Things should pick up this week, but markets will likely be decreasingly busy over the next four weeks. However a...

November remains a positive month in capital markets, although equities had a neutral week and longer bond prices have fallen back. UK government bonds (Gilts) have been the best performing bond market in the past few weeks, but the tax cuts announced...

Overview: Inflation genie back in the bottle?Last week was another good one for most investors. In sterling terms, the strongest equity markets were in Europe with the DAX up 4.5% over the week, the biggest winners being small and mid-sized firms. Risk...

Inflation genie back in the bottle? This week was another good one for most investors. In sterling terms, the strongest equity markets were in Europe with the DAX up 4.5% since last Friday afternoon. The biggest winners have been small and mid-sized...

Not so Sunny for the Solar Stocks  It’s been a cloudy year for Solar Energy stocks this year, the MAC Global Solar Energy index which tracks 41 of the largest Solar Energy related companies worldwide is down over 42% YTD and over...

Overview: Back-pedalling central bankersThe turnaround rally in stock and bond markets – prompted by dovish central bank comments – petered out towards the end of last week, with central bankers at pains to reverse their messaging, or at least reaffirm their commitment...

The turnaround rally in stock and bond markets – started by last week’s dovish central bank comments – petered out towards the end of this week, with central bankers seemingly at pains to reverse their messaging or at least reaffirm their continued...

Overview: Central bank dovishness proves contagiousLast week, we noted how negative sentiment in stock markets can become a self-perpetuating destructive force for an entire economy as the investing public feels the heat of feeling poorer (at least on paper). But seven days...

Just how much change a week can bring to markets was amply visible during the last seven days. Last Friday we wrote about how negative sentiment in stock markets can turn into a self-perpetuating destructive force for an entire economy as the...

Overview: The resilience narrative comes under pressureIn recent times, a fall in bond yields (and therefore a rise in bond prices) would go alongside rises in equity prices, particularly the mega-cap growth consumer-related techs like Amazon, Alphabet (Google), Microsoft and Apple. However,...